TG Branfalt

Florida agriculture regulators have finalized rules for the manufacturing and sales of medical cannabis-infused edible products; the rules must also be considered by health regulators, however, before becoming law.

At least two Canadian financial institutions are turning away U.S.-based cannabis companies due to the plant’s ongoing federal prohibition there.

Indiana farmers will get to participate in a proposed hemp advisory committee if the crop is successfully legalized in the state.

Texas hemp regulators plan to enforce just the minimal federal standards to help farmers and foster the industry’s growth.

New rules in New Mexico will remove some criminal penalties for cannabis possession while another new law offers critical changes to the state’s medical cannabis program.

Under decriminalization rules passed April 1, adults in Israel will no longer be prosecuted for simple home growing and low-level cannabis possession.

Colorado Gov. Jared Polis is expected to sign the state’s new cannabis-for-autism bill as lawmakers consider additional reforms, including options for social use and cannabis delivery businesses.

Georgia lawmakers have approved a bill establishing comprehensive medical cannabis reforms; the governor is expected to sign the bill into law.

Vireo Health has acquired Massachusetts licensed cannabis company Mayflower Botanicals; it is Vireo’s first acquisition in a state with an adult-use program.

The FDA is planning a public hearing next month to consider the safety, manufacturing, product quality, marketing, labeling, and sale of federally regulated CBD products.

LA prosecutors and nonprofit tech organization Code for America are teaming up to help guide as many as 50,000 cannabis convicts down the path to expungement.

The new law authorizes the state treasurer to select financial institutions who will provide banking services via a competitive bidding process to state-legal cannabis companies.

Maryland cannabis operator Curio Wellness has withdrawn the lawsuit filed late last month against the state’s Medical Cannabis Commission over its plan to issue new cannabis licenses to minority-owned companies.

The deal, which is expected to be finalized in June, would give Origin House shareholders 0.8428 of Cresco stock for each share held.

Legislative leaders had packaged the medical cannabis and recreational bills together hoping to garner more ‘yes’ votes for legalization, but may need to take separate action to benefit medical patients if the adult-use bill continues to flounder.

At least one New York village has announced plans to sue the state government if lawmakers approve statewide legalization legislation.

Unlicensed dispensaries in Michigan have been given yet another extension for licensure after dispensary owners successfully argued they were only denied a license because the state erroneously recorded its tax payments.

Walgreens is the latest major pharmacy chain to announce it will carry hemp-derived CBD products.

A Massachusetts investigation aims to uncover whether or not two of the state’s large cannabis companies have thwarted state rules regarding the number of licenses that a single company can hold.

A piece of emergency legislation in Maine has passed into law, aligning the state’s definition of industrial hemp with language in the federal farm bill.

Guam lawmakers narrowly passed a legalization bill on Wednesday; the bill now goes to Gov. Lou Leon Guerrero for her final decision on legalizing cannabis in the U.S. territory.

The agreement will establish a new company, Houseplant, which plans to offer three strains – Houseplant Sativa, Houseplant Hybrid, and Houseplant Indica – over the coming months.

Maryland medical cannabis firm Curio is filing suit against the state Medical Cannabis Commission for allegedly violating its own rules by soliciting license applications without first completing a supply and demand survey.

In addition to the new legalization language being considered, the committee also advanced legislation to add opioid use disorder to the state’s medical cannabis qualifying conditions list.